全部股東
股東類型
- 上市公司42.45%
- 公眾及其他32.40%
- 機構投資者16.15%
- 對沖基金7.64%
- 個人與內幕人士1.36%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Lin BioScience, Inc. | 42.45% | 1,709.53 萬 | 1.01% | +0 | 28/02/2026 |
Darwin Global Management Limited | 7.64% | 307.72 萬 | 0.13% | +1.98 萬 | 30/06/2026 |
Paradigm Biocapital Advisors LP | 3.06% | 123.29 萬 | 0.23% | +11.81 萬 | 30/06/2026 |
RTW Investments, LP | 1.78% | 71.53 萬 | 0.04% | +0 | 30/06/2026 |
Millennium Management LLC | 1.23% | 49.46 萬 | 0.22% | -7.55 萬 | 30/06/2026 |
Maverick Capital, Ltd. | 0.98% | 39.63 萬 | -- | +39.63 萬 | 30/06/2026 |
Eventide Asset Management, LLC | 0.97% | 39.08 萬 | 0.06% | +3.32 萬 | 30/06/2026 |
Deerfield Management Company, L.P. | 0.89% | 35.72 萬 | 0.11% | +5.32 萬 | 30/06/2026 |
Yu-Hsin LinChairman of the Board of Directors & CEO | 0.63% | 25.31 萬 | 0.25% | -10.08 萬 | |
Holocene Advisors, LP | 0.62% | 25.10 萬 | 0.63% | -24.35 萬 | 30/06/2026 |
Logos Global Management, L.P. | 0.62% | 25.00 萬 | -- | +25.00 萬 | 30/06/2026 |
Morgan Stanley | 0.58% | 23.36 萬 | 0.18% | +7.56 萬 | 30/06/2026 |
Hao-Yuan ChuangCFO & Director | 0.57% | 23.13 萬 | 0.17% | -6.78 萬 | |
UBS Asset Management AG | 0.56% | 22.50 萬 | 1.39% | -54.34 萬 | 30/06/2026 |
Citadel Advisors LLC | 0.46% | 18.62 萬 | 0.46% | +18.42 萬 | 30/06/2026 |
The Goldman Sachs Group, Inc. | 0.41% | 16.62 萬 | 0.14% | +6.07 萬 | 30/06/2026 |
Affinity Asset Advisors, LLC | 0.41% | 16.50 萬 | 0.24% | +10.00 萬 | 30/06/2026 |
MPM BioImpact LLC | 0.34% | 13.72 萬 | 0.12% | +4.92 萬 | 30/06/2026 |
Bank of America Corporation | 0.30% | 12.21 萬 | 0.30% | +11.99 萬 | 30/06/2026 |
Patient Square Capital, LP | 0.27% | 11.00 萬 | 0.02% | -6,684.00 | 30/06/2026 |